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will include a minimum of 2600 users worldwide. CONCLU-
SION: BeautyQol is the ﬁrst and, to date, the only user centered
instrument speciﬁc in cosmetology that is being developed simul-
taneously in 13 countries. BeautyQol is going to be a very valu-
able tool for national and international assessment of various
cosmetic strategies.
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Quality of life (QoL) in patients with dermatological conditions
is evaluated using generic and speciﬁc instruments. Even though
these instruments are created to give as a result one or more
total scores, the analysis of the answers to the single items may
give important information on QoL impairment of patients.
OBJECTIVES: To investigate the QoL of patients with vitiligo,
also analyzing single questions from a QoL instrument.
METHODS: Single items from the Skindex-29 questionnaire, a
QoL dermatology-speciﬁc instrument, were analyzed in 181
patients with vitiligo. Answers to the Skindex-29 items were
given on a 5-point scale, from “never” to “all the time”.
RESULTS: The QoL problems more frequently experienced
often or all the time were: worry of the disease getting worse
(60%) or being a serious condition (40%), anger (37%), embar-
rassment (34%), depression (31%), affect on having social life
affected (28%), and shame (28%). The association of QoL
impairment with the probable presence of depression or anxiety,
evaluated using the 12-item General Health Questionnaire
(GHQ-12), was very strong for all the items, and remained
signiﬁcant also when taking into account simultaneously gender,
age, clinical severity, family history, and localization of vitiligo.
CONCLUSION: The answers to single items from a
dermatology-speciﬁc quality of life questionnaire may provide
clinicians with relevant additional information on the physical
and mental health status of patients.
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OBJECTIVE: Chronic diseases have a long-term negative impact
on quality of life (QoL). Few studies have investigated the impact
of glaucoma on patients’ QoL in comparison to other chronic
diseases observed in patients with similar demographics. We
performed a systematic literature search to assess QoL in glau-
coma, osteoporosis, type 2 diabetes mellitus, and dementia.
METHODS: We searched MEDLINE, BIOSIS, EMBASE, and
Cochrane databases. RESULTS: A total of 146 QoL publications
were identiﬁed (some reported >1 instrument): Short-Form
Health Survey [SF]-36 was used in 77 (glaucoma = 8; osteoporo-
sis = 25; diabetes = 40; dementia = 4), SF-12 in 19 (glau-
coma = 1, osteoporosis = 5, diabetes = 9, dementia = 4), SF-20
in 7 (glaucoma = 1, diabetes = 6), EuroQol EQ-5D in 29 (glau-
coma = 2; osteoporosis = 9; diabetes = 9; dementia = 9), Sickness
Impact Proﬁle (SIP) in 6 (glaucoma = 2; osteoporosis = 1; diabe-
tes = 3, dementia = 0), and Health Utilities Index-Mark III
(HUI-III) in 17 (glaucoma + diabetes = 1; diabetes only = 11;
osteoporosis = 3; dementia = 2). Similar trends were observed
across studies using SF-36, -12 or -20: social functioning
domains were affected least, and physical domains affected most
in glaucoma. In general, QoL was affected to a similar degree in
all diseases. By EQ-5D, in glaucoma, utility decreased with
increasing glaucomatous damage. The highest mean values using
EQ-5D were similar across all four diseases; mean overall utility
scores were generally slightly lower (QoL impacted more) in
osteoporosis, diabetes and dementia than glaucoma. Mean SIP
scores increased (QoL decreased) with increasing severity of
glaucoma. Total SIP scores for glaucoma were similar to those for
diabetes. By HUI-III, QoL impact also was similar in glaucoma
and diabetes. CONCLUSION: QoL in glaucoma decreases with
increasing disease severity; physical domains are affected more
than social domains. Although there are limited published QoL
studies in glaucoma, its impact on QoL appears to be broadly
consistent with other serious chronic diseases. Further efforts
towards diagnosing and treating glaucoma, to reduce ﬁnancial
burden on health care systems and society, are warranted.
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OBJECTIVE: Vision disorders have a negative impact on quality
of life (QoL). While the impairment of QoL in central-vision loss
(CVL) disorders, e.g. age-related macular degeneration (ARMD),
is widely acknowledged, the QoL impact of peripheral-vision
loss (PVL) disorders, e.g. glaucoma, is less well-known. We per-
formed a systematic literature search to assess the effect on
QoL of PVL versus CVL. METHODS: We searched MEDLINE,
BIOSIS, EMBASE, and Cochrane databases. RESULTS: A total
of 87 publications were identiﬁed (some reported >1 instrument):
Short-Form Health Survey (SF)-36 was used in 23 (PVL = 2;
CVL = 21), SF-12 in 6 (PVL = 1; CVL = 5), National Eye Insti-
tute Visual Function Questionnaire (NEI-VFQ)-51 in 11
(PVL = 4; CVL = 7), NEI-VFQ-39 in 9 (PVL = 1; CVL = 8), NEI-
VFQ-25 in 36 (PVL = 11; CVL = 25), EuroQol EQ-5D in 3
(PVL = 1; CVL = 2), Visual Function-14 (VF-14) in 20 (PVL = 1;
CVL = 19), Sickness Impact Proﬁle (SIP) in 4 (PVL = 2 [1 study];
CVL = 2), and Impact of Vision Impairment (IVI) in 1 (including
3 diseases: glaucoma, retinopathy [PVL] and ARMD [CVL]). By
SF-36, vitality was impacted most in PVL. By SF-36 and SF-12,
generally, mental health domains were affected more in PVL than
CVL; physical domains were affected most in CVL. Mental
aspects of QoL were affected more in PVL than CVL in all
NEI-VFQ studies; ARMD and glaucoma impacted different
domains. QoL was generally lower in glaucoma than ARMD,
although results varied amongst studies. By EQ-5D, QoL in
PVL and CVL were similarly affected. By VF-14 and SIP, CVL
impacted QoL slightly more than PVL. By SIP, psychosocial and
physical domains were affected equally in PVL. In the IVI study,
PVL affected QoL slightly more than CVL (except glaucoma on
the social scale). CONCLUSION: Results showed in general,
PVL and CVL disorders have a signiﬁcant impact on QoL. More
QoL research towards better understanding patients’ concerns
with their PVL and CVL disorders are warranted.
PSS37
MAPPINGTHE DERMATOLOGY QUALITY OF LIFE INDEX
(DLQI) TO HEALTH-RELATED UTILITYVIATHE SF-12 IN
SUBJECTSWITH ECZEMA
Currie CJ1, Sidhu M2, Poole CD3
1Cardiff University, Cardiff, UK, 2Astellas Pharma Europe Ltd, Staines,
Middlesex, UK, 3Pharmatelligence, Cardiff, South Glamorgan, UK
OBJECTIVE: The purpose of this study was to conduct a statis-
tical mapping between patient reported disease-speciﬁc quality of
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